Streetbeat News

Products Services

ITI

Iteris, Inc. (NASDAQ:ITI) has been selected to support the deployment of Intelligent Transportation System (ITS) technologies in Metro Cebu, Philippines, as part of a USTDA-funded modernization project aimed at improving public mobility.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:45 pm

AIXI

Xiao-I has partnered with an AI company to advance smart city technologies. This collaboration aims to enhance urban management and services through AI-driven solutions.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:41 pm

AMT

LEN

META

On CNBC's 'Halftime Report Final Trades,' experts discussed Meta Platforms, American Tower Corporation, and Lennar Corporation. Meta Platforms is launching a third-party fact-checking program for Threads. American Tower reported strong Q1 2024 results, and Lennar posted mixed Q1 financial results.

Portfolio Pulse from Avi Kapoor

May 16, 2024 | 12:41 pm

BBW

PARA

Build-A-Bear Workshop has announced an in-store celebration in partnership with Paramount Pictures for the feature film 'IF,' which will be in theaters on May 17. This collaboration aims to enhance customer engagement and drive sales through themed products and events.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:41 pm

BX

Blackstone has announced its acquisition of a majority stake in Priority Software, a leading provider of business management software. This move is expected to enhance Blackstone's portfolio in the technology sector.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:38 pm

BLDE

Blade Air Mobility has partnered with Ocean Casino Resort to offer flights for guests from Manhattan to Atlantic City.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:34 pm

GH

Guardant Health, Inc. (NASDAQ:GH) will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting, showcasing the effectiveness of its Shield™ blood test for colorectal cancer (CRC) screening.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

ATXI

Avenue Therapeutics has completed the last patient visit in its Phase 1b/2a clinical trial of AJ201 for Spinal and Bulbar Muscular Atrophy.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

GCTK

Glucotrack announced that its implantable glucose monitor has successfully completed 30 days of a 60-day preclinical study.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:32 pm

ARDX

Ardelyx, Inc. (NASDAQ:ARDX) presented new data on XPHOZAH® (tenapanor) at the NKF 2024 Spring Clinical Meetings, highlighting additional positive clinical observations. The company is also hosting an Exhibitor Showcase on hyperphosphatemia management.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 12:30 pm